TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Reduction in overall Clinical COPD Questionnaire (CCQ) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount and incidence of homologous transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: change in GMFM-88 measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in attention / concentration measures
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: change in figural memory measures
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: change in reaction behavior measures
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change in logical reasoning measures
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Multimodality Cardiology Assessment- EKG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Multimodality Cardiology Assessment- Echocardiogram with Strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Multimodality Cardiology Assessment- Coronary Artery Calcium (CAC) CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PHQ-9 and GAD-7 scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time of 1st membrane exchange
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PHQ Scores Over Time
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Occurrence of Musculoskeletal Diagnoses Over Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Relative Change in Lung Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Behaviour change
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Rate of complete response (CR) or partial response (PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asthma Control Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Immune factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants With Acceptable OCT Image Quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Experience/Satisfaction: Difference in topbox scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rates of unplanned hospitalization and ER visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Changes in Whole Lung Mucociliary Clearance (MCC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in the Number of Drinks Consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Craving-Baseline Adjusted Total Area Under the Curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Systolic blood pressure during pneumoperitoneum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Diastolic blood pressure during pneumoperitoneum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Mean Arterial blood pressure during pneumoperitoneum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Heart Rate during pneumoperitoneum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total Dose of Oxycodone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: verbal descriptor scale (VDS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in metabolic panel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PrEP continuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient wait time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: survival over time
Endpoint domain: Mortality/survival
Primary endpoint: Change in ONH blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Documentation of atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Relative Reduction of 20% in Mean Anterior Myocardial Infarct Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Per-patient Rate of Composite Major Adverse Cardiac Events (MACE)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Grade 3-4 Esophagitis
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Grade 3-4 Pneumonitis
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Grade 3-4 Myelosuppression
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline messenger ribonucleic acid expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in self-assessed walking disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in subjective impression of well-being (MSIS-29)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline in subjective impression of well-being (EQ-5D)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Readmission rate to emergency department
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Risk of graft failure at 24 months
Endpoint domain: Mortality/survival
Primary endpoint: Local control of disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histological improvement in the severity of NASH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Number of Participants Randomized
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change of functional capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of distance traveled during a six-minute walk test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of body mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of treatment initiation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percent of Subjects With Treatment Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantity of tracheal secretions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Size of fibroids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of late rectal toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Who Reported Any Treatment Emergent Serious Adverse Events (TESAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Who Reported Any Unexpected Treatment Emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Time to first gastrointestinal-related event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: CD40-ligand levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: soluble P-selectin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum concentrations of s-100B
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum concentrations of NSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of dropped markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Marker misplacements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implantation-related side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Freedom from major device- or procedure- related serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment Satisfaction and Acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Treatment Engagement: Call Completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Maximum tolerated dose of gemcitabine hydrochloride
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Model for normal, dysplastic and cancerous tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Safety of multiple intralesional administration of MORAb-028
Endpoint domain: Adverse events/effects
Primary endpoint: Coronary zero flow pressure (Pzf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Difference in energy intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Difference in intake by weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Difference in energy density consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of top quality embryos produced
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Extent of lymph node dissection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: concentration of 8-isoprostane and total nitrate and nitrite (NOx) in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Function evaluated with TUG test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Language (Total Standard Score)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Intra-operative exposure to x-ray radiation
Endpoint domain: Adverse events/effects
Primary endpoint: Neurological functional impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants experiencing Serious Adverse Events (SAEs) and adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Vital signs (blood pressure, pulse rate, respiratory rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability assessed by investigator
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: presence of mediocarpal osteoarthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: presence of scapho-trapezoidal trapezoid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: presence of non-consolidation of radio-scapho-lunar arthrodesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mortality or need for mechanical ventilation
Endpoint domain: Mortality/survival
Primary endpoint: Recurrence of Nasal Polyps Requiring Intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Progression of aortic dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Primary care visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Practice performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residual Cancer Burden (RCB) 0-1 Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in knee varus/valgus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in peak vertical ground reaction force
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in anterior-posterior centre of pressure displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in time taken to complete a sit-to-stand task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of clinical significant cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Lesion pattern on Magnetic Resonance Imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of pregnants who developed preeclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Number of pregnants who developed IUGR alone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Number of pregnants who developed other obstetric complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: 10 meter sprint time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: no recurrence of atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Tumor localization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Utilization rates of genomic and epigenetic features
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Heart Rate acquisition time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: score of modified Rankin Scale (MRS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Antipsychotic Medication Adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Blood Glucose Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pleurodesis success at 3 months post randomization
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients severely down-regulated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TOOL questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PANSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Young Mania Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: incidence of hypercalciuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in standardized height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sum score of the Z-scores of the performed standardized neuropsychological tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Bronchitis Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Short term outcome (none of death, IVH °3 or 4, PVL, pneumothorax, BPD, NEC °2 or 3, ROP °3 to 5)
Endpoint domain: Mortality/survival
Primary endpoint: Change in Resting Anal Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prevalence of diabetes mellitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in glycosylated hemoglobin (A1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the perfusate concentration versus time curve (AUC) of platinum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration versus time curve (AUC) of platinum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vision Clarity During the Day - Distance Vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival without chronic lung disease (CLD)
Endpoint domain: Mortality/survival
Primary endpoint: Diagnostic and prognostic value of new biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cognitive function as measured by ADAS-Cog
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Response as assessed by Investigator Global Assessment (IGA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EuroQoL (Quality of Life)-5 Dimensions (EQ-5D) Scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Core Outcome Measures Index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Spontaneous infection of ascitic fluid
Endpoint domain: Adverse events/effects
Primary endpoint: Change of pain measured by visual analogue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of wake episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of wake episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in L4 Paraspinal Cross-Sectional Area Asymmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: changes in sleep patterns
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Total score of the Symptom Checklist Attention-Deficit/Hyperactivity Disorder (SCL-ADHD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: spectrum of toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Composite vascular
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Composite major bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Development of antibiotic associated diarrhoea
Endpoint domain: Adverse events/effects
Primary endpoint: Development of Clostridium difficile associated diarrhoea
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Mean Serum Phosphorus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline of the Surgical Recovery Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to complete a progress note
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Satisfaction during the urodynamic study testing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in VAS symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite acute major adverse event rate
Endpoint domain: Adverse events/effects
Primary endpoint: Freedom from Atrial Fibrillation (AF)/Atrial Flutter (AFL)/Atrial Tachycardia (AT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical Pain Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: short-term complete response (CR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term complete response (CR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence rate at 24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of patients with adequate bowel preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in age and gender adjusted BMI z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of patients with CDAI remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with endoscopic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recoil (lumen loss > 30%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Percentage of subjects who proceed to radical nephrectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Clinical tolerability of Cabozantinib
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical impact of EUS-guided microbiopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients with a functioning graft
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 24 hours proteinuria changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Addiction severity of betelnut
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under plasma concentration versus time curve of ganciclovir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent volume of distribution of ganciclovir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Terminal half-life of ganciclovir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak concentration of ganciclovir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numerical pain rating scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total small vessel density of sublingual microcirculation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EMI assessment during TENS-application
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum testosterone levels (Cavg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Serum testosterone levels (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes